Personalization of loco-regional care for primary breast cancer patients (part 1)

2014 Kyoto Breast Cancer Consensus Conference

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the first of a two part conference scene, consensus recommendations for axillary management are presented and focus on the following topics: indications for completion axillary lymph node dissection in primary surgical patients with ≤2 macrometastases or any sentinel nodal deposits after PST; the timing of sentinel lymph node biopsy in the context of PST; use of axillary irradiation as a component of primary treatment plans and the role of intraoperative node assessment in the post-Z0011 era.

Original languageEnglish (US)
Pages (from-to)1297-1300
Number of pages4
JournalFuture Oncology
Volume11
Issue number9
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Primary Health Care
Breast Neoplasms
Therapeutics
Sentinel Lymph Node Biopsy
Genetic Testing
Genetic Predisposition to Disease
Lymph Node Excision
Radiotherapy
Neoplasms

Keywords

  • axillary conserving therapy
  • breast cancer
  • loco-regional care
  • preoperative systemic therapy
  • sentinel lymph node biopsy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Personalization of loco-regional care for primary breast cancer patients (part 1). / 2014 Kyoto Breast Cancer Consensus Conference.

In: Future Oncology, Vol. 11, No. 9, 01.05.2015, p. 1297-1300.

Research output: Contribution to journalArticle

2014 Kyoto Breast Cancer Consensus Conference 2015, 'Personalization of loco-regional care for primary breast cancer patients (part 1)', Future Oncology, vol. 11, no. 9, pp. 1297-1300. https://doi.org/10.2217/fon.15.65
2014 Kyoto Breast Cancer Consensus Conference. / Personalization of loco-regional care for primary breast cancer patients (part 1). In: Future Oncology. 2015 ; Vol. 11, No. 9. pp. 1297-1300.
@article{eec6146c5d5448acbb692691adc13553,
title = "Personalization of loco-regional care for primary breast cancer patients (part 1)",
abstract = "The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the first of a two part conference scene, consensus recommendations for axillary management are presented and focus on the following topics: indications for completion axillary lymph node dissection in primary surgical patients with ≤2 macrometastases or any sentinel nodal deposits after PST; the timing of sentinel lymph node biopsy in the context of PST; use of axillary irradiation as a component of primary treatment plans and the role of intraoperative node assessment in the post-Z0011 era.",
keywords = "axillary conserving therapy, breast cancer, loco-regional care, preoperative systemic therapy, sentinel lymph node biopsy",
author = "{2014 Kyoto Breast Cancer Consensus Conference} and Masakazu Toi and Winer, {Eric P.} and Benson, {John R.} and Takashi Inamoto and Forbes, {John F.} and {Von Minckwitz}, Gunter and Robertson, {John Fr} and Grobmyer, {Stephen R.} and Ismail Jatoi and Hironobu Sasano and Ian Kunkler and Ho, {Alice Y.} and Chikako Yamauchi and Chow, {Louis Wc} and Huang, {Chiun Sheng} and Wonshik Han and Shinzaburo Noguchi and Pegram, {Mark D.} and Hideko Yamauchi and Lee, {Eun Sook} and Larionov, {Alexey A.} and Bevilacqua, {Jose Lb} and Michio Yoshimura and Tomoharu Sugie and Akira Yamauchi and Krop, {Ian E.} and Noh, {Dong Young} and Vicki Klimberg",
year = "2015",
month = "5",
day = "1",
doi = "10.2217/fon.15.65",
language = "English (US)",
volume = "11",
pages = "1297--1300",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Personalization of loco-regional care for primary breast cancer patients (part 1)

AU - 2014 Kyoto Breast Cancer Consensus Conference

AU - Toi, Masakazu

AU - Winer, Eric P.

AU - Benson, John R.

AU - Inamoto, Takashi

AU - Forbes, John F.

AU - Von Minckwitz, Gunter

AU - Robertson, John Fr

AU - Grobmyer, Stephen R.

AU - Jatoi, Ismail

AU - Sasano, Hironobu

AU - Kunkler, Ian

AU - Ho, Alice Y.

AU - Yamauchi, Chikako

AU - Chow, Louis Wc

AU - Huang, Chiun Sheng

AU - Han, Wonshik

AU - Noguchi, Shinzaburo

AU - Pegram, Mark D.

AU - Yamauchi, Hideko

AU - Lee, Eun Sook

AU - Larionov, Alexey A.

AU - Bevilacqua, Jose Lb

AU - Yoshimura, Michio

AU - Sugie, Tomoharu

AU - Yamauchi, Akira

AU - Krop, Ian E.

AU - Noh, Dong Young

AU - Klimberg, Vicki

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the first of a two part conference scene, consensus recommendations for axillary management are presented and focus on the following topics: indications for completion axillary lymph node dissection in primary surgical patients with ≤2 macrometastases or any sentinel nodal deposits after PST; the timing of sentinel lymph node biopsy in the context of PST; use of axillary irradiation as a component of primary treatment plans and the role of intraoperative node assessment in the post-Z0011 era.

AB - The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the first of a two part conference scene, consensus recommendations for axillary management are presented and focus on the following topics: indications for completion axillary lymph node dissection in primary surgical patients with ≤2 macrometastases or any sentinel nodal deposits after PST; the timing of sentinel lymph node biopsy in the context of PST; use of axillary irradiation as a component of primary treatment plans and the role of intraoperative node assessment in the post-Z0011 era.

KW - axillary conserving therapy

KW - breast cancer

KW - loco-regional care

KW - preoperative systemic therapy

KW - sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=84929244495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929244495&partnerID=8YFLogxK

U2 - 10.2217/fon.15.65

DO - 10.2217/fon.15.65

M3 - Article

VL - 11

SP - 1297

EP - 1300

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 9

ER -